Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

ASP Isotopes Inc. Common Stock

Basic Materials US ASPI

7.28USD
0.10(1.39%)

Last update at 2026-06-22T20:20:00Z

Day Range

6.937.43
LowHigh

52 Week Range

3.9214.49
LowHigh

Fundamentals

  • Previous Close 7.18
  • Market Cap637.07M
  • Volume4654634
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-55.87900M
  • Revenue TTM23.85M
  • Revenue Per Share TTM0.29
  • Gross Profit TTM 3.40M
  • Diluted EPS TTM-2.11

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -159.56100M -32.31200M -16.30026M -4.94514M -
Minority interest -15.24900M 0.09M 0.00789M - -
Net income -175.09200M -32.33400M -16.28623M -4.79123M -
Selling general administrative 48.24M 24.81M 15.42M 3.83M -
Selling and marketing expenses - - - - -
Gross profit 3.40M 1.60M 0.14M - -
Reconciled depreciation 1.91M 0.47M 0.04M - -
Ebit -158.98600M -32.05300M -16.18171M -5.09905M -7.82413M
Ebitda -157.07400M -31.58200M -16.14428M -5.24958M -
Depreciation and amortization 1.91M 0.47M 0.04M -0.15053M -
Non operating income net other - - - - -
Operating income -57.19100M -26.35400M -16.04200M -5.09905M -
Other operating expenses 81.04M 30.50M 16.48M 5.10M -
Interest expense 0.57M 0.26M 0.12M 0.15M -
Tax provision 0.28M 0.11M -0.00613M - -
Interest income 6.79M 1.24M 0.00642M 0.00338M -
Net interest income 6.21M 0.98M 0.00642M 0.00338M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.28M 0.11M -0.00613M -0.15391M -
Total revenue 23.85M 4.14M 0.43M 0.00000M -
Total operating expenses 60.60M 27.95M 16.18M 5.10M -
Cost of revenue 20.44M 2.54M 0.29M - -
Total other income expense net -102.37000M -5.95800M -0.25826M 0.15M -
Discontinued operations - - - - -
Net income from continuing ops -159.84300M -32.42273M -13.42887M -4.94514M -
Net income applicable to common shares - - - - -7.82378M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 512.88M 94.35M 30.19M 12.50M 7.14M
Intangible assets 1.48M 3168097.83M 3267099.73M - -
Earning assets - - - - -
Other current assets 4.62M 3.05M 1.66M 0.91M 0.27M
Total liab 249.98M 43.18M 11.36M 2.68M 1.14M
Total stockholder equity 204.15M 47.90M 16.30M 9.82M 6.00M
Deferred long term liab - - - - -
Other current liab 12.42M 3.53M 2.81M 0.50M 0.12M
Common stock 1.12M 0.72M 0.49M 0.36M 0.21M
Capital stock 1.12M 0.72M 0.49M 0.36M 0.21M
Retained earnings -231.26500M -56.17288M -23.83930M -7.55307M -2.60793M
Other liab - - - - -
Good will 8.57M 3.17M 3.27M - -
Other assets - -0.28604M 0.00000M 0.14M -
Cash 285.56M 61.89M 7.91M 2.39M 2.95M
Cash and equivalents - - - - -
Total current liabilities 32.70M 7.06M 5.67M 1.94M 0.30M
Current deferred revenue 0.88M 0.88M 0.88M - 0.04M
Net debt -69.60300M -24.14412M -5.76554M -1.56694M -2.02713M
Short term debt 13.64M 1.62M 0.87M 0.08M 0.08M
Short long term debt 12.88M 0.94M 0.47M 0.03M 0.05M
Short long term debt total 215.96M 37.75M 2.14M 0.82M 0.93M
Other stockholder equity 431.76M 105.52M 40.57M 16.76M 8.38M
Property plant equipment - - - - 3.92M
Total current assets 398.14M 65.74M 10.51M 3.30M 3.22M
Long term investments 47.31M 0.00000M - - -
Net tangible assets - - - 9.82M 6.00M
Short term investments 47.74M - - - -
Net receivables 51.71M 0.73M 0.94M - -
Long term debt 200.79M 34.87M - - -
Inventory 8.49M 0.07M - - -
Accounts payable 5.75M 1.02M 1.11M 1.35M 0.06M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 2.54M -2.16431M -0.92098M 0.26M 0.02M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 5.87M -3.81446M 3267101.53M 0.14M -
Deferred long term asset charges - - - - -
Non current assets total 114.74M 28.60M 19.68M 9.19M 3.92M
Capital lease obligations 2.28M 1.93M 1.67M 0.79M 0.88M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -47.74500M -11.37240M -2.09269M -4.47316M -
Change to liabilities - - - 0.00000M 0.18M
Total cashflows from investing activities -89.99500M -11.37240M -2.45319M - -8.96463M
Net borrowings 41.54M 25.72M -0.18053M - 0.14M
Total cash from financing activities 350.80M 82.53M 13.39M 6.64M 19.50M
Change to operating activities - - - -0.53671M -0.89366M
Net income -175.09200M -32.33358M -16.29413M -4.94514M -7.82378M
Change in cash 223.67M 54.47M 5.52M -0.56458M 8.86M
Begin period cash flow 61.89M 7.91M 2.39M 2.95M -
End period cash flow 285.56M 61.89M 7.91M 2.39M 2.95M
Total cash from operating activities -37.78000M -16.69536M -5.41239M -2.93989M -1.73308M
Issuance of capital stock 320.30M 53.09M 10.00M 8.12M -
Depreciation 1.91M 0.47M 0.04M 0.07M 0.06M
Other cashflows from investing activities -29.97400M -1.69727M - - -
Dividends paid - 2.78M - - -
Change to inventory -0.31500M -0.06764M 0.22M - -
Change to account receivables -0.45400M -0.50595M 0.24M - -
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.40200M 2.78M -0.56347M -1.46586M -0.67800M
Change to netincome - - - 1.90M 6.75M
Capital expenditures 9.65M 11.37M 2.33M 4.47M 8.96M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -3.62900M -2.62289M 1.16M 0.03M -
Stock based compensation 16.02M 8.56M 8.74M 2.00M -
Other non cash items 139.07M 2.41M 0.92M -0.02796M -
Free cash flow -47.43400M -28.06776M -7.74374M -7.41306M -

Peer Comparison

Sector: Basic Materials Industry: Chemicals

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ASPI
ASP Isotopes Inc. Common Stock		 0.10 1.39% 7.28 - 54.35 26.71 3.37 23.96 -12.1733
SHECY
Shin-Etsu Chemical Co Ltd ADR		 -0.6 2.57% 22.77 18.83 12.18 0.03 2.62 0.03 0.06
SHECF
Shin-Etsu Chemical Co. Ltd		 0.48 1.03% 47.30 18.24 12.11 0.03 2.68 0.03 0.06
BFFAF
BASF SE NA O.N.		 - -% 53.99 33.31 25.58 0.93 1.43 1.13 8.85
BASFY
BASF SE ADR		 0.09 0.65% 13.97 33.15 25.25 0.93 1.41 1.13 8.85

Reports Covered

Stock Research & News

View All

Profile

ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs. The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which separates isotopes. It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry. In addition, the company develops Zinc-68, Nickel-64, and Xenon-129/136 for the nuclear medical industry; Lithium-7, Uranium-235, and Chlorine-37 for the energy industry; and Germanium-70/72/74 for semiconductor markets. The company was incorporated in 2021 and is based in Dallas, Texas.

ASP Isotopes Inc. Common Stock

2200 Ross Avenue, Dallas, TX, United States, 75201

Key Executives

Name Title Year Born
Mr. Paul Elliot Mann CEO & Chairman 1976
Mr. Robert Ainscow Interim Chief Financial Officer 1976
Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. Chief Technology Officer & Director 1960
Mr. Paul Elliot Mann President, CEO & Executive Chairman 1977
Mr. Robert Ainscow CFO & COO 1977
Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. CTO & Director 1961
Mr. Paul Elliot Mann C.F.A. President, CEO & Executive Chairman 1976
Mr. Robert Ainscow Chief Operating Officer 1976
Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. CTO & Director 1960
Ms. Heather Kiessling Chief Financial Officer 1964

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.